Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
PLoS One
    January 2018
  1. LIN CY, Lin TH, Chen CC, Chen MC, et al
    Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.
    PLoS One. 2018;13:e0190497.
    >> Share

  2. FAN F, Wang R, Boulbes DR, Zhang H, et al
    Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway.
    PLoS One. 2018;13:e0190070.
    >> Share

  3. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    >> Share

  4. ZHANG Y, Liu H, Li L, Ai M, et al
    Correction: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2018;13:e0191587.
    >> Share

  5. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    >> Share

  6. MUGHINI-GRAS L, Schaapveld M, Kramers J, Mooij S, et al
    Increased colon cancer risk after severe Salmonella infection.
    PLoS One. 2018;13:e0189721.
    >> Share

  7. MAKONDI PT, Lee CH, Huang CY, Chu CM, et al
    Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    PLoS One. 2018;13:e0189582.
    >> Share

  8. GOMES SE, Pereira DM, Roma-Rodrigues C, Fernandes AR, et al
    Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells.
    PLoS One. 2018;13:e0191607.
    >> Share

  9. SILVA DAS, Tremblay MS, Souza MFM, Mooney M, et al
    Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study.
    PLoS One. 2018;13:e0190943.
    >> Share

  10. LI F, Li Q, Wu X
    Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
    PLoS One. 2018;13:e0192494.
    >> Share

  11. CATALANO C, da Silva Filho MI, Frank C, Jiraskova K, et al
    Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.
    PLoS One. 2018;13:e0192385.
    >> Share

  12. HE Y, Penney ME, Negandhi AA, Parfrey PS, et al
    XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer.
    PLoS One. 2018;13:e0192316.
    >> Share

  13. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    >> Share

  14. SHETH H, Northwood E, Ulrich CM, Scherer D, et al
    Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
    PLoS One. 2018;13:e0192223.
    >> Share

  15. FRANZ J, Grunebaum J, Schafer M, Mulac D, et al
    Rhombic organization of microvilli domains found in a cell model of the human intestine.
    PLoS One. 2018;13:e0189970.
    >> Share

  16. MARCUELLO M, Mayol X, Felipe-Fumero E, Costa J, et al
    Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.
    PLoS One. 2018;13:e0192958.
    >> Share

  17. CHOI JW, Kim DK, Kim JK, Lee EJ, et al
    A retrospective analysis on the relationship between intraoperative hypothermia and postoperative ileus after laparoscopic colorectal surgery.
    PLoS One. 2018;13:e0190711.
    >> Share

  18. GALLERY M, Zhang J, Bradley DP, Brauer P, et al
    A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    PLoS One. 2018;13:e0191046.
    >> Share

  19. JUNG YS, Park CH, Kim NH, Park JH, et al
    Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    PLoS One. 2018;13:e0191125.
    >> Share

  20. WANG H, Du K, Qu J, Chandarana H, et al
    Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.
    PLoS One. 2018;13:e0190883.
    >> Share

  21. SCHIRRIPA M, Zhang W, Yang D, Cao S, et al
    NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
    PLoS One. 2018;13:e0193640.
    >> Share

  22. MARLICZ W, Poniewierska-Baran A, Rzeszotek S, Bartoszewski R, et al
    A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
    PLoS One. 2018;13:e0189337.
    >> Share

  23. ARELAKI S, Arampatzioglou A, Kambas K, Sivridis E, et al
    Mast cells co-expressing CD68 and inorganic polyphosphate are linked with colorectal cancer.
    PLoS One. 2018;13:e0193089.
    >> Share

  24. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    >> Share

  25. FENG S, Zhou Q, Yang B, Li Q, et al
    The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.
    PLoS One. 2018;13:e0192208.
    >> Share

  26. JIAO X, Liu W, Mahdessian H, Bryant P, et al
    Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
    PLoS One. 2018;13:e0193547.
    >> Share

  27. ORTIZ-ORTIZ KJ, Tortolero-Luna G, Rios-Motta R, Veintidos-Feliu A, et al
    Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    PLoS One. 2018;13:e0194415.
    >> Share

  28. HOLM M, Saraswat M, Joenvaara S, Ristimaki A, et al
    Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    PLoS One. 2018;13:e0195354.
    >> Share

  29. LU J, Hu X, Meng Y, Zhao H, et al
    The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer.
    PLoS One. 2018;13:e0194804.
    >> Share

  30. SULZYC-BIELICKA V, Kolodziejczyk L, Jaczewska S, Bielicki D, et al
    Colorectal cancer and Cryptosporidium spp. infection.
    PLoS One. 2018;13:e0195834.
    >> Share

  31. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    >> Share

  32. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    >> Share

  33. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    >> Share

  34. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    >> Share

  35. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0197008.
    >> Share

  36. KOJIMA K, Nakamura T, Ohbu M, Katoh H, et al
    Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    PLoS One. 2018;13:e0194785.
    >> Share

    January 2017
  37. ZHANG S, Deng Z, Yao C, Huang P, et al
    AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
    PLoS One. 2017;12:e0169585.
    >> Share

  38. HUANG WS, Kuo YH, Kuo HC, Hsieh MC, et al
    CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45.
    PLoS One. 2017;12:e0168989.
    >> Share

  39. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    >> Share

  40. WU R, Feng J, Yang Y, Dai C, et al
    Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer.
    PLoS One. 2017;12:e0170003.
    >> Share

  41. LI Y, Wang WY, Xiao JH, Xu F, et al
    Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2017;12:e0167868.
    >> Share

  42. FROUWS MA, Reimers MS, Swets M, Bastiaannet E, et al
    The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
    PLoS One. 2017;12:e0170775.
    >> Share

  43. QIN M, Zhang J, Xu C, Peng P, et al
    Knockdown of NIK and IKKbeta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kappaBeta Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK.
    PLoS One. 2017;12:e0170595.
    >> Share

  44. SOO HC, Chung FF, Lim KH, Yap VA, et al
    Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
    PLoS One. 2017;12:e0170551.
    >> Share

  45. KINAR Y, Akiva P, Choman E, Kariv R, et al
    Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
    PLoS One. 2017;12:e0171759.
    >> Share

  46. PENG Y, Yang H, Ye Q, Zhou H, et al
    Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.
    PLoS One. 2017;12:e0172097.
    >> Share

  47. ZHAI H, Shi Y, Chen X, Wang J, et al
    CacyBP/SIP promotes the proliferation of colon cancer cells.
    PLoS One. 2017;12:e0169959.
    >> Share

  48. FAN G, Zhang K, Yang X, Ding J, et al
    Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2017;12:e0171991.
    >> Share

  49. ALI H, Bitar MS, Al Madhoun A, Marafie M, et al
    Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    PLoS One. 2017;12:e0171690.
    >> Share

  50. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0170823.
    >> Share

  51. LI P, Xiao Z, Braciak TA, Ou Q, et al
    A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    PLoS One. 2017;12:e0172799.
    >> Share

  52. PRIETO I, Del Puerto-Nevado L, Gonzalez N, Portal-Nunez S, et al
    Colon cancer modulation by a diabetic environment: A single institutional experience.
    PLoS One. 2017;12:e0172300.
    >> Share

  53. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    >> Share

  54. WEBER L, Al-Refae K, Ebbert J, Jagers P, et al
    Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis.
    PLoS One. 2017;12:e0172491.
    >> Share

  55. SARSHEKEH AM, Advani S, Overman MJ, Manyam G, et al
    Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0173345.
    >> Share

  56. THEAN LF, Wong YH, Lo M, Loi C, et al
    Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
    PLoS One. 2017;12:e0173772.
    >> Share

  57. TASHIRO T, Okuyama H, Endo H, Kawada K, et al
    In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.
    PLoS One. 2017;12:e0174151.
    >> Share

  58. GOEDE SL, Rabeneck L, van Ballegooijen M, Zauber AG, et al
    Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    PLoS One. 2017;12:e0172864.
    >> Share

  59. CARLSON GE, Martin EW, Shirure VS, Malgor R, et al
    Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.
    PLoS One. 2017;12:e0173747.
    >> Share

  60. SHINKINS B, Nicholson BD, Primrose J, Perera R, et al
    The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    PLoS One. 2017;12:e0171810.
    >> Share

  61. SIMICZYJEW A, Mazur AJ, Dratkiewicz E, Nowak D, et al
    Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
    PLoS One. 2017;12:e0173709.
    >> Share

  62. HUANG WY, Ho CL, Lee CC, Hsiao CW, et al
    Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
    PLoS One. 2017;12:e0174280.
    >> Share

  63. YANG M, Xiao X, Xing X, Li X, et al
    KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    PLoS One. 2017;12:e0174140.
    >> Share

  64. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    >> Share

  65. BERGER AW, Schwerdel D, Welz H, Marienfeld R, et al
    Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
    PLoS One. 2017;12:e0174308.
    >> Share

  66. NAGAPPAN A, Lee WS, Yun JW, Lu JN, et al
    Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    PLoS One. 2017;12:e0174591.
    >> Share

  67. ANDRES-FRANCH M, Galiana A, Sanchez-Hellin V, Ochoa E, et al
    Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors.
    PLoS One. 2017;12:e0174305.
    >> Share

  68. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Correction: Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2017;12:e0175659.
    >> Share

  69. ZHOU Y, Zhang X, Zhang J, Fang J, et al
    LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.
    PLoS One. 2017;12:e0175122.
    >> Share

  70. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    >> Share

  71. BURMEISTER K, Quagliata L, Andreozzi M, Eppenberger-Castori S, et al
    Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.
    PLoS One. 2017;12:e0175563.
    >> Share

  72. CAO G, Cheng D, Ye L, Pan Y, et al
    Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
    PLoS One. 2017;12:e0175284.
    >> Share

  73. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Correction: Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0176574.
    >> Share

  74. ZHU B, Wu X, Wu B, Pei D, et al
    The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.
    PLoS One. 2017;12:e0176068.
    >> Share

  75. BAILEY KL, Agarwal E, Chowdhury S, Luo J, et al
    TGFbeta/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.
    PLoS One. 2017;12:e0176096.
    >> Share

  76. SHARMA A, Vatapalli R, Abdelfatah E, Wyatt McMahon K, et al
    Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
    PLoS One. 2017;12:e0176139.
    >> Share

  77. KIM HJ, Jo MJ, Kim BR, Kim JL, et al
    Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
    PLoS One. 2017;12:e0176834.
    >> Share

  78. SHIN SJ, Chun SM, Kim TI, Kim YJ, et al
    Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.
    PLoS One. 2017;12:e0176340.
    >> Share

  79. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    >> Share

  80. LI Y, Li J, Liu H, Liu Y, et al
    Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0177235.
    >> Share

  81. LAKATOS E, Salehi-Reyhani A, Barclay M, Stumpf MPH, et al
    Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.
    PLoS One. 2017;12:e0177336.
    >> Share

  82. Correction: Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0177586.
    >> Share

  83. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    >> Share

  84. LEE JY, Lee MK, Kim NK, Chu SH, et al
    Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.
    PLoS One. 2017;12:e0176929.
    >> Share

  85. Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0178275.
    >> Share

  86. GONZALEZ-DONQUILES C, Alonso-Molero J, Fernandez-Villa T, Vilorio-Marques L, et al
    The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.
    PLoS One. 2017;12:e0177549.
    >> Share

  87. PARK JY, Kim SH, Lee SM, Lee JS, et al
    CT volumetric measurement of colorectal cancer helps predict tumor staging and prognosis.
    PLoS One. 2017;12:e0178522.
    >> Share

  88. LI J, Li Y, Liu H, Liu Y, et al
    The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    PLoS One. 2017;12:e0178515.
    >> Share

  89. OSUMI H, Shinozaki E, Suenaga M, Wakatsuki T, et al
    Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
    PLoS One. 2017;12:e0176745.
    >> Share

  90. KNUDSEN KN, Lindebjerg J, Nielsen BS, Hansen TF, et al
    MicroRNA-200b is downregulated in colon cancer budding cells.
    PLoS One. 2017;12:e0178564.
    >> Share

  91. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    >> Share

  92. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    >> Share

  93. BURON A, Auge JM, Sala M, Roman M, et al
    Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.
    PLoS One. 2017;12:e0179864.
    >> Share

  94. WANG J, Du S, Wang J, Fan W, et al
    The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0179670.
    >> Share

  95. ZHANG Z, Chang Y, Zhang J, Lu Y, et al
    HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway.
    PLoS One. 2017;12:e0179741.
    >> Share

  96. KIM EK, Cho JH, Kim E, Kim YJ, et al
    Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.
    PLoS One. 2017;12:e0181183.
    >> Share

  97. LOPES-RAMOS CM, Barros BP, Koyama FC, Carpinetti PA, et al
    E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer.
    PLoS One. 2017;12:e0181153.
    >> Share

  98. RASMUSSEN SL, Krarup HB, Sunesen KG, Johansen MB, et al
    Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    PLoS One. 2017;12:e0180809.
    >> Share

  99. POTOCNIK N, Perse M, Cerar A, Injac R, et al
    Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    PLoS One. 2017;12:e0181632.
    >> Share

  100. URIBE DJ, Mandell EK, Watson A, Martinez JD, et al
    The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
    PLoS One. 2017;12:e0179979.
    >> Share

  101. LOCK FE, Babaian A, Zhang Y, Gagnier L, et al
    A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancer.
    PLoS One. 2017;12:e0180659.
    >> Share

  102. MAKONDI PT, Chu CM, Wei PL, Chang YJ, et al
    Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    PLoS One. 2017;12:e0180616.
    >> Share

  103. ZHANG Y, Liu H, Li L, Ai M, et al
    Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2017;12:e0181852.
    >> Share

  104. SIESING C, Sorbye H, Dragomir A, Pfeiffer P, et al
    High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    PLoS One. 2017;12:e0182512.
    >> Share

  105. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    >> Share

  106. KUTUK O, Aytan N, Karakas B, Kurt AG, et al
    Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.
    PLoS One. 2017;12:e0182809.
    >> Share

  107. LI Q, Wang Y, Lai Y, Xu P, et al
    HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling.
    PLoS One. 2017;12:e0182588.
    >> Share

  108. GLISZCZYNSKA A, Niezgoda N, Gladkowski W, Switalska M, et al
    Isoprenoid-phospholipid conjugates as potential therapeutic agents: Synthesis, characterization and antiproliferative studies.
    PLoS One. 2017;12:e0172238.
    >> Share

    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    >> Share

  110. HENLEY AB, Yang L, Chuang KL, Sahuri-Arisoylu M, et al
    Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'.
    PLoS One. 2017;12:e0170917.
    >> Share

  111. ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
    Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
    PLoS One. 2017;12:e0169875.
    >> Share

  112. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    >> Share

  113. ALMASUD AA, Giles KH, Miklavcic JJ, Martins KJB, et al
    Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer.
    PLoS One. 2017;12:e0183576.
    >> Share

  114. PELLINO G, Simillis C, Qiu S, Rasheed S, et al
    Social media and colorectal cancer: A systematic review of available resources.
    PLoS One. 2017;12:e0183031.
    >> Share

  115. KASHIWAGI K, Inoue N, Yoshida T, Bessyo R, et al
    Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy.
    PLoS One. 2017;12:e0174155.
    >> Share

  116. OTTERPOHL KL, Gould KA
    Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.
    PLoS One. 2017;12:e0172247.
    >> Share

  117. ZHAO J, Salomon MP, Shibata D, Curtis C, et al
    Early mutation bursts in colorectal tumors.
    PLoS One. 2017;12:e0172516.
    >> Share

  118. LEWITOWICZ P, Gluszek S, Koziel D, Horecka-Lewitowicz A, et al
    Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability.
    PLoS One. 2017;12:e0172381.
    >> Share

  119. ARSIC N, Ho-Pun-Cheung A, Evelyne C, Assenat E, et al
    The p53 isoform delta133p53ss regulates cancer cell apoptosis in a RhoB-dependent manner.
    PLoS One. 2017;12:e0172125.
    >> Share

  120. LIEDER B, Hoi JK, Holik AK, Geissler K, et al
    The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells.
    PLoS One. 2017;12:e0171580.
    >> Share

  121. FASTERIUS E, Raso C, Kennedy S, Rauch N, et al
    A novel RNA sequencing data analysis method for cell line authentication.
    PLoS One. 2017;12:e0171435.
    >> Share

  122. KIM KH, Yeo SG, Yoo BC, Myung JK, et al
    Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.
    PLoS One. 2017;12:e0171232.
    >> Share

  123. PURCELL RV, Pearson J, Aitchison A, Dixon L, et al
    Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia.
    PLoS One. 2017;12:e0171602.
    >> Share

  124. HUANG TC, Lee PT, Wu MH, Huang CC, et al
    Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    PLoS One. 2017;12:e0181034.
    >> Share

  125. QI L, Zhang W, Cheng Z, Tang N, et al
    Study on molecular mechanism of ANOS1 promoting development of colorectal cancer.
    PLoS One. 2017;12:e0182964.
    >> Share

  126. PEREIRA AAL, Morelli MP, Overman M, Kee B, et al
    Clinical utility of circulating cell-free DNA in advanced colorectal cancer.
    PLoS One. 2017;12:e0183949.
    >> Share

  127. KOIRE A, Kim YW, Wang J, Katsonis P, et al
    Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction.
    PLoS One. 2017;12:e0174766.
    >> Share

  128. HUA Y, Ma X, Liu X, Yuan X, et al
    Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma.
    PLoS One. 2017;12:e0174461.
    >> Share

  129. THORVALDSEN TE, Pedersen NM, Wenzel EM, Stenmark H, et al
    Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and beta-Catenin Degradation.
    PLoS One. 2017;12:e0170508.
    >> Share

  130. ROSSI E, Bizzarro T, Martini M, Longatto-Filho A, et al
    The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience.
    PLoS One. 2017;12:e0168625.
    >> Share

  131. JEPPESEN M, Hagel G, Glenthoj A, Vainer B, et al
    Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine.
    PLoS One. 2017;12:e0183074.
    >> Share

  132. HANKINS SC, Brimhall BB, Kankanala V, Austin GL, et al
    A low-volume polyethylene glycol solution was associated with an increased suboptimal bowel preparation rate but had similar recommendations for an early repeat colonoscopy, procedure times, and adenoma detection rates.
    PLoS One. 2017;12:e0176265.
    >> Share

  133. STEPPELER C, Sodring M, Egelandsdal B, Kirkhus B, et al
    Effects of dietary beef, pork, chicken and salmon on intestinal carcinogenesis in A/J Min/+ mice.
    PLoS One. 2017;12:e0176001.
    >> Share

  134. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    >> Share

  135. ISHIGURO S, Uppalapati D, Goldsmith Z, Robertson D, et al
    Exopolysaccharides extracted from Parachlorella kessleri inhibit colon carcinoma growth in mice via stimulation of host antitumor immune responses.
    PLoS One. 2017;12:e0175064.
    >> Share

  136. BINDER GALLIMIDI A, Nussbaum G, Hermano E, Weizman B, et al
    Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.
    PLoS One. 2017;12:e0174343.
    >> Share

  137. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    >> Share

  138. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    >> Share

  139. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    >> Share

  140. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    >> Share

  141. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    >> Share

  142. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    >> Share

  143. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    >> Share

  144. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    >> Share

  145. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    >> Share

  146. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    >> Share

  147. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    >> Share

  148. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    >> Share

  149. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    >> Share

  150. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    >> Share

  151. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    >> Share

  152. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    >> Share

  153. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    >> Share

  154. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    >> Share

  155. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  156. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    >> Share

  157. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    >> Share

  158. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    >> Share

  159. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    >> Share

  160. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    >> Share

  161. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    >> Share

  162. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    >> Share

  163. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    >> Share

  164. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    >> Share

  165. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    >> Share

  166. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    >> Share

  167. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    >> Share

  168. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    >> Share

  169. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    >> Share

  170. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    >> Share

  171. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    >> Share

  172. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    >> Share

  173. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    >> Share

  174. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    >> Share

  175. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    >> Share

  176. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    >> Share

  177. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    >> Share

  178. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    >> Share

  179. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    >> Share

  180. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    >> Share

  181. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    >> Share

  182. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    >> Share

  183. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    >> Share

  184. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    >> Share

  185. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    >> Share

  186. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    >> Share

  187. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    >> Share

  188. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    >> Share

  189. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    >> Share

  190. YU Z, Chen Z, Wu J, Li Z, et al
    Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0188139.
    >> Share

  191. PARK H, Cho S, Woo H, Park SK, et al
    Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.
    PLoS One. 2017;12:e0188465.
    >> Share

  192. BIEN SA, Auer PL, Harrison TA, Qu C, et al
    Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.
    PLoS One. 2017;12:e0186518.
    >> Share

  193. HUO T, Canepa R, Sura A, Modave F, et al
    Colorectal cancer stages transcriptome analysis.
    PLoS One. 2017;12:e0188697.
    >> Share

  194. ROVELLI C, Poli A, Galli L, Cernuschi M, et al
    Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.
    PLoS One. 2017;12:e0186367.
    >> Share

  195. ZHANG Z, Zheng F, Yu Z, Hao J, et al
    XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    PLoS One. 2017;12:e0186900.
    >> Share

  196. HWANG IC, Chang J, Park SM
    Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    PLoS One. 2017;12:e0189114.
    >> Share

  197. BERRY RS, Xiong MJ, Greenbaum A, Mortaji P, et al
    High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.
    PLoS One. 2017;12:e0188799.
    >> Share

  198. LORCA V, Rueda D, Martin-Morales L, Poves C, et al
    Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
    PLoS One. 2017;12:e0187312.
    >> Share

  199. HOEDJES M, de Kruif A, Mols F, Bours M, et al
    An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study.
    PLoS One. 2017;12:e0189178.
    >> Share

  200. SERRANO-VILLAR S, Hernandez-Novoa B, de Benito A, Del Romero J, et al
    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
    PLoS One. 2017;12:e0188851.
    >> Share

  201. GRAF JF, Zavodszky MI
    Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.
    PLoS One. 2017;12:e0188878.
    >> Share

  202. MA L, Wang L, Shan Y, Nafees M, et al
    Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
    PLoS One. 2017;12:e0188665.
    >> Share

  203. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    >> Share

  204. VIRGONE-CARLOTTA A, Lemasson M, Mertani HC, Diaz JJ, et al
    In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
    PLoS One. 2017;12:e0188100.
    >> Share

  205. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    >> Share

  206. KOENIG A, Krug S, Mueller D, Barth PJ, et al
    Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
    PLoS One. 2017;12:e0188876.
    >> Share

  207. OSMAN M, Benamrouz S, Guyot K, Baydoun M, et al
    High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients.
    PLoS One. 2017;12:e0189422.
    >> Share

  208. GONG J, Bai T, Zhang L, Qian W, et al
    Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro.
    PLoS One. 2017;12:e0189257.
    >> Share

  209. O'NEIL BH, Wallmark JM, Lorente D, Elez E, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
    PLoS One. 2017;12:e0189848.
    >> Share

    January 2016
  210. CHEN X, Deane NG, Lewis KB, Li J, et al
    Comparison of Nanostring nCounter(R) Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
    PLoS One. 2016;11:e0153784.
    >> Share

  211. HUO H, Zhou Z, Qin J, Liu W, et al
    Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells.
    PLoS One. 2016;11:e0154605.
    >> Share

  212. VOGTMANN E, Hua X, Zeller G, Sunagawa S, et al
    Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing.
    PLoS One. 2016;11:e0155362.
    >> Share

  213. CHOU CK, Chen SL, Yen AM, Chiu SY, et al
    Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.
    PLoS One. 2016;11:e0155276.
    >> Share

  214. FOSTER C, Haviland J, Winter J, Grimmett C, et al
    Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study.
    PLoS One. 2016;11:e0155434.
    >> Share

  215. BUHL IK, Gerster S, Delorenzi M, Jensen T, et al
    Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
    PLoS One. 2016;11:e0155123.
    >> Share

  216. LI B, Gan A, Chen X, Wang X, et al
    Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0155095.
    >> Share

  217. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    >> Share

  218. AAN DE STEGGE WB, van Leeuwen BL, Elferink MA, de Bock GH, et al
    The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.
    PLoS One. 2016;11:e0155608.
    >> Share

  219. VAN HELDEN EJ, Hoekstra OS, Boellaard R, Roth C, et al
    Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0155178.
    >> Share

  220. GORGES TM, Stein A, Quidde J, Hauch S, et al
    Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(R) System and the AdnaTest(R).
    PLoS One. 2016;11:e0155126.
    >> Share

  221. DI CARO G, Carvello M, Pesce S, Erreni M, et al
    Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    PLoS One. 2016;11:e0156669.
    >> Share

  222. HUSSAIN T, Chang HY, Luu NP, Pollack CE, et al
    The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
    PLoS One. 2016;11:e0155789.
    >> Share

  223. ADAMS SV, Ceballos R, Newcomb PA
    Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry.
    PLoS One. 2016;11:e0156534.
    >> Share

  224. PALANIAPPAN A, Ramar K, Ramalingam S
    Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression.
    PLoS One. 2016;11:e0156665.
    >> Share

  225. EYKING A, Reis H, Frank M, Gerken G, et al
    MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
    PLoS One. 2016;11:e0156871.
    >> Share

  226. HAMIDOU Z, Chibaudel B, Hebbar M, Hug de Larauze M, et al
    Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.
    PLoS One. 2016;11:e0157067.
    >> Share

  227. ALKHAYAL KA, Awadalia ZH, Vaali-Mohammed MA, Al Obeed OA, et al
    Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
    PLoS One. 2016;11:e0155236.
    >> Share

  228. VELUCHAMY JP, Spanholtz J, Tordoir M, Thijssen VL, et al
    Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0157830.
    >> Share

  229. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    >> Share

  230. LIN PC, Yang YF, Tyan YC, Hsiao ES, et al
    Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
    PLoS One. 2016;11:e0158844.
    >> Share

  231. NEGM OH, Hamed MR, Schoen RE, Whelan RL, et al
    Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0156971.
    >> Share

  232. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    >> Share

  233. NOVESKI P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, et al
    Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
    PLoS One. 2016;11:e0146264.
    >> Share

  234. SATO KA, Hachiya T, Iwaya T, Kume K, et al
    Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    PLoS One. 2016;11:e0146275.
    >> Share

  235. TIPTIRI-KOURPETI A, Spyridopoulou K, Santarmaki V, Aindelis G, et al
    Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147960.
    >> Share

  236. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    >> Share

  237. MAIDEN SL, Petrova YI, Gumbiner BM
    Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.
    PLoS One. 2016;11:e0148574.
    >> Share

  238. LEE LS, Seng KY, Wang LZ, Yong WP, et al
    Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
    PLoS One. 2016;11:e0147681.
    >> Share

  239. CEA SORIANO L, Soriano-Gabarro M, Garcia Rodriguez LA
    The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    PLoS One. 2016;11:e0159179.
    >> Share

  240. TAKAYA A, Hirohashi Y, Murai A, Morita R, et al
    Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    PLoS One. 2016;11:e0158903.
    >> Share

  241. PHANG CW, Karsani SA, Sethi G, Abd Malek SN, et al
    Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0148775.
    >> Share

  242. REYES-ZURITA FJ, Rufino-Palomares EE, Garcia-Salguero L, Peragon J, et al
    Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells.
    PLoS One. 2016;11:e0146178.
    >> Share

  243. JIMENEZ S, Gascon S, Luquin A, Laguna M, et al
    Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer.
    PLoS One. 2016;11:e0159136.
    >> Share

  244. ZHOU J, Chang L, Guan Y, Yang L, et al
    Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
    PLoS One. 2016;11:e0159708.
    >> Share

  245. KIM SH, Park YY, Cho SN, Margalit O, et al
    Kruppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.
    PLoS One. 2016;11:e0159899.
    >> Share

  246. GRANDE R, Natoli C, Ciancola F, Gemma D, et al
    Treatment of Metastatic Colorectal Cancer Patients >/=75 Years Old in Clinical Practice: A Multicenter Analysis.
    PLoS One. 2016;11:e0157751.
    >> Share

  247. COSTA-CABRAL S, Brough R, Konde A, Aarts M, et al
    CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    PLoS One. 2016;11:e0149099.
    >> Share

  248. KUAN CS, See Too WC, Few LL
    Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147886.
    >> Share

  249. SETH C, Ruiz I Altaba A
    Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
    PLoS One. 2016;11:e0160904.
    >> Share

  250. CHEN W, Li Q, Fan Y, Li D, et al
    Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique.
    PLoS One. 2016;11:e0151773.
    >> Share

  251. NAM SK, Yun S, Koh J, Kwak Y, et al
    BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    PLoS One. 2016;11:e0151865.
    >> Share

  252. ERIKSEN AH, Andersen RF, Pallisgaard N, Sorensen FB, et al
    MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    PLoS One. 2016;11:e0150593.
    >> Share

  253. MARTINO-ECHARRI E, Brocardo MG, Mills KM, Henderson BR, et al
    Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of beta-Catenin Degradation-Competent Axin Puncta.
    PLoS One. 2016;11:e0150484.
    >> Share

  254. PINTO AT, Pinto ML, Velho S, Pinto MT, et al
    Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation.
    PLoS One. 2016;11:e0160891.
    >> Share

  255. CHANG YJ, Cheng YW, Lin RK, Huang CC, et al
    Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
    PLoS One. 2016;11:e0160550.
    >> Share

  256. KANG MR, Park KH, Yang JO, Lee CW, et al
    miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
    PLoS One. 2016;11:e0160961.
    >> Share

  257. JI K, Zhang M, Chu Q, Gan Y, et al
    The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160125.
    >> Share

  258. NANDA N, Dhawan DK, Bhatia A, Mahmood A, et al
    Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach.
    PLoS One. 2016;11:e0151539.
    >> Share

  259. CHEN JY, Tsai WS, Shao HJ, Wu JC, et al
    Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
    PLoS One. 2016;11:e0149633.
    >> Share

  260. ZHANG J, Yi M, Zha L, Chen S, et al
    Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis.
    PLoS One. 2016;11:e0147218.
    >> Share

  261. KIM H, Myoung S, Koom WS, Kim NK, et al
    MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
    PLoS One. 2016;11:e0146235.
    >> Share

  262. YAN H, Hu K, Wu W, Li Y, et al
    Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    PLoS One. 2016;11:e0159954.
    >> Share

  263. SONG LP, Wang HY
    Modeling and Control of Colorectal Cancer.
    PLoS One. 2016;11:e0161349.
    >> Share

  264. JO P, Konig A, Schirmer M, Kitz J, et al
    Heterogeneity of KRAS Mutation Status in Rectal Cancer.
    PLoS One. 2016;11:e0153278.
    >> Share

  265. OKERBERG ES, Hainley A, Brown H, Aban A, et al
    Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1alpha by Chemical Proteomics.
    PLoS One. 2016;11:e0152934.
    >> Share

  266. BAJENOVA O, Gorbunova A, Evsyukov I, Rayko M, et al
    The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing.
    PLoS One. 2016;11:e0161256.
    >> Share

  267. ILIC I, Jankovic S, Ilic M
    Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
    PLoS One. 2016;11:e0161912.
    >> Share

  268. CHEN YG, Chen MQ, Guo YY, Li SC, et al
    Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    PLoS One. 2016;11:e0153944.
    >> Share

  269. SUNDSTROM A, Grabocka E, Bar-Sagi D, Mishra B, et al
    Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia.
    PLoS One. 2016;11:e0153623.
    >> Share

  270. ABULI A, Castells A, Bujanda L, Lozano JJ, et al
    Genetic Variants Associated with Colorectal Adenoma Susceptibility.
    PLoS One. 2016;11:e0153084.
    >> Share

  271. ISSOP L, Ostuni MA, Lee S, Laforge M, et al
    Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.
    PLoS One. 2016;11:e0152919.
    >> Share

  272. MILLER CL, Muthupalani S, Shen Z, Drees F, et al
    Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.
    PLoS One. 2016;11:e0152940.
    >> Share

  273. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    >> Share

  274. FALCONE E, Grandoni L, Garibaldi F, Manni I, et al
    Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.
    PLoS One. 2016;11:e0153658.
    >> Share

  275. CATALAN V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, et al
    Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.
    PLoS One. 2016;11:e0162189.
    >> Share

  276. CHEN J, Raju GS, Jogunoori W, Menon V, et al
    Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas.
    PLoS One. 2016;11:e0153933.
    >> Share

  277. GU X, Gao XS, Qin S, Li X, et al
    Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
    PLoS One. 2016;11:e0163523.
    >> Share

  278. BOTTICELLI A, Borro M, Onesti CE, Strigari L, et al
    Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
    PLoS One. 2016;11:e0163105.
    >> Share

  279. TSUKIHARA H, Tsunekuni K, Takechi T
    Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines.
    PLoS One. 2016;11:e0163961.
    >> Share

  280. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2016;11:e0163209.
    >> Share

  281. SOLASSOL J, Vendrell J, Markl B, Haas C, et al
    Multi-Center Evaluation of the Fully Automated PCR-Based Idylla KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    PLoS One. 2016;11:e0163444.
    >> Share

  282. HUANG WS, Hsieh MC, Huang CY, Kuo YH, et al
    The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.
    PLoS One. 2016;11:e0159927.
    >> Share

  283. CHANG YT, Huang MY, Yeh YS, Huang CW, et al
    A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
    PLoS One. 2016;11:e0163264.
    >> Share

  284. BUDHATHOKI S, Yamaji T, Iwasaki M, Sawada N, et al
    Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study.
    PLoS One. 2016;11:e0164648.
    >> Share

  285. COMAS M, Mendivil J, Andreu M, Hernandez C, et al
    Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
    PLoS One. 2016;11:e0164666.
    >> Share

  286. SUN X, Hu Y, Zhang L, Hu C, et al
    Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs.
    PLoS One. 2016;11:e0164590.
    >> Share

  287. LOPE V, Fernandez de Larrea N, Perez-Gomez B, Martin V, et al
    Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
    PLoS One. 2016;11:e0164620.
    >> Share

  288. LIN J, Hiraoka K, Watanabe T, Kuo T, et al
    Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
    PLoS One. 2016;11:e0165581.
    >> Share

  289. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    >> Share

  290. LENNARD KS, Goosen RW, Blackburn JM
    Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.
    PLoS One. 2016;11:e0166282.
    >> Share

  291. MIGUCHI M, Hinoi T, Shimomura M, Adachi T, et al
    Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    PLoS One. 2016;11:e0166422.
    >> Share

  292. KAMIZA AB, Hsieh LL, Tang R, Chien HT, et al
    TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
    PLoS One. 2016;11:e0167354.
    >> Share

  293. YAP R, Wilkins S, Staples M, Oliva K, et al
    The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
    PLoS One. 2016;11:e0167271.
    >> Share

  294. CHANDLER PD, Akinkuolie AO, Tobias DK, Lawler PR, et al
    Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
    PLoS One. 2016;11:e0165615.
    >> Share

  295. ALAJEZ NM
    Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    PLoS One. 2016;11:e0167455.
    >> Share

  296. TOMINAGA T, Nonaka T, Sumida Y, Hidaka S, et al
    The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    PLoS One. 2016;11:e0167967.
    >> Share

  297. KAI M, Niinuma T, Kitajima H, Yamamoto E, et al
    TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    PLoS One. 2016;11:e0168281.
    >> Share

  298. RAMAKER K, Bade S, Rockendorf N, Meckelein B, et al
    Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0168801.
    >> Share

  299. ZHANG ZY, Li C, Gao W, Yin XW, et al
    A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.
    PLoS One. 2016;11:e0168156.
    >> Share

  300. VARGAS T, Moreno-Rubio J, Herranz J, Cejas P, et al
    3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
    PLoS One. 2016;11:e0168423.
    >> Share

  301. MULLINS CS, Huhns M, Krohn M, Peters S, et al
    Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples.
    PLoS One. 2016;11:e0153349.
    >> Share

  302. WANG X, Ji P, Zhang Y, LaComb JF, et al
    Aberrant DNA Methylation: Implications in Racial Health Disparity.
    PLoS One. 2016;11:e0153125.
    >> Share

  303. GALISSIER T, Schneider C, Nasri S, Kanagaratnam L, et al
    Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?
    PLoS One. 2016;11:e0154326.
    >> Share

  304. BHARDWAJ M, Kim NH, Paul S, Jakhar R, et al
    5-Hydroxy-7-Methoxyflavone Triggers Mitochondrial-Associated Cell Death via Reactive Oxygen Species Signaling in Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0154525.
    >> Share

  305. CARCHMAN EH, Matkowskyj KA, Meske L, Lambert PF, et al
    Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
    PLoS One. 2016;11:e0164273.
    >> Share

  306. PAN CH, Chang CC, Su CT, Tsai PS, et al
    Trends in Irritable Bowel Syndrome Incidence among Taiwanese Adults during 2003-2013: A Population-Based Study of Sex and Age Differences.
    PLoS One. 2016;11:e0166922.
    >> Share

  307. KUNISAWA S, Fushimi K, Imanaka Y
    Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
    PLoS One. 2016;11:e0166269.
    >> Share

  308. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
    Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
    PLoS One. 2016;11:e0155669.
    >> Share

    January 2015
  309. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
    The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
    PLoS One. 2015;10:e0123080.
    >> Share

  310. MBANG PA, Kowalkowski MA, Amirian ES, Giordano TP, et al
    Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans.
    PLoS One. 2015;10:e0142966.
    >> Share

  311. YING J, Lin C, Wu J, Guo L, et al
    Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    PLoS One. 2015;10:e0144731.
    >> Share

  312. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
    KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PLoS One. 2015;10:e0144825.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016